Mylan Pharmaceuticals Inc. v. Warner Chilcott Public Limited Company et al
REPLY to Response to Motion re MOTION to Exclude / Warner Chilcott's Motion to Exclude the Declaration and Testimony of Expert Gordon Rausser [Redacted Public Version] re, 236 MOTION to Exclude [Public Redacted Version] re: 262 REPLY
Holding that a record consisting of a preliminary report, an amended report, an affidavit prepared to meet the adversary's Daubert challenge, and multiple depositions was sufficient to obviate the need for a Daubert hearing
Holding that a district court could not consider, for Rule 702 analysis of reliability of an expert's methods, a challenge to the expert's credibility based on a past embezzlement charge
Holding that fixing a “list price” would constitute a per se antitrust violation even if the list price was only a “guide to likely transaction purchases”